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Abstract
The present work describes the abrupt emergence of Klebsiella
pneumoniae carbapenemase (KPC) and characterizes the ﬁrst 79
KPC-producing enterobacteria from Argentina (isolated from
2006 to 2010). The emergence of blaKPC-2 was characterized by
two patterns of dispersion: the ﬁrst was the sporadic occurrence
in diverse enterobacteria from distant geographical regions, har-
bouring plasmids of different incompatibility groups and blaKPC-2 in
an unusual genetic environment ﬂanked by ISKpn8-DblaTEM-1 and
ISKpn6-like. blaKPC-2 was associated with IncL/M transferable plas-
mids; the second was the abrupt clonal spread of K. pneumoniae
ST258 harbouring blaKPC-2 in Tn4401a.
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The emergence and rapid dissemination of Klebsiella pneumo-
niae carbapenemase (KPC)-producing Gram-negative bacilli
has become an important therapeutic and infection control
problem in the healthcare setting [1]. The worldwide spread
of KPC-producing K. pneumoniae strains has revealed the
successful dissemination of a major clone deﬁned as
sequence type (ST)258 [2–4]. blaKPC has been commonly
associated with Tn4401, which is possibly responsible for its
acquisition [5,6]. A different blaKPC environment was
described in plasmids from Chinese enterobacteria, where
blaKPC-2 was associated with a Tn801-like transposon [7].
Moreover, ST11 was demonstrated to be the dominant
clone of KPC-producing K. pneumoniae in China, where
ST258 was not detected [8].
We previously reported the emergence of blaKPC in
Enterobacteriaceae from Argentina (2006), and designed
an algorithm to detect class A carbapenemases and metallo-
b-lactamases at the level of the clinical microbiology
laboratory [9,10]. Since 2008, as the National Reference Lab-
oratory in Antimicrobial Resistance (NRLAR), we have used
the algorithm to implement active surveillance of such carba-
penemases among 432 laboratories across Argentina that
participate in the National Quality Control Programme in
Bacteriology (Argentinean Ministry of Health). All enterobac-
teria were screened through the algorithm: isolates that
showed (i) imipenem inhibition zones £21 mm, (ii) resistance
or intermediate resistance to expanded-spectrum cephalo-
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sporins and (iii) positive synergy between the disks of carba-
penems and 3-aminophenyl-boronic acid were suspected of
KPC production and sent to the NRLAR. Possible interfer-
ence by AmpC was overcome by using the oxacillin-based
modiﬁed Hodge test [11].
In this study, we included the ﬁrst two KPC producers
detected in Argentina in 2006 [9], plus the 77 consecutive
isolates (one per patient) that were conﬁrmed at the NRLAR
by PCR as KPC producers (subsequently characterized as
blaKPC-2 by sequencing). These 77 isolates were referred
between January 2008 and July 2010 from 30 hospitals from
ﬁve distant geographical regions (no. isolates/no. hospitals):
Buenos Aires City (54/19), Buenos Aires Province (16/8),
Mendoza (4/1), Neuque´n (2/1), and Formosa (1/1).
From January 2008 to July 2009, isolates of Citrobacter
freundii (n = 2), K. pneumoniae (n = 5), Serratia marcescens
(n = 1), Enterobacter cloacae (n = 2) and Escherichia coli
(n = 1) were recovered from six hospitals (four regions).
However, from August 2009, the number of blaKPC-2 isolates
and the number of hospitals affected increased dramatically,
mostly owing to K. pneumoniae recovered from Buenos Aires
City and Province (Fig. 1).
Pulsed-ﬁeld gel electrophoresis (PFGE) was performed as
previously described [12], and the results were analysed
according to the van Belkum guidelines [13]. Five types were
observed among the 69 K. pneumoniae isolates: K1 (63 iso-
lates); K2 (three isolates); and K3–K5 (one isolate each). No
genotypic relationship was found among the three C. freundii
or the ﬁve E. cloacae isolates.
Multilocus sequence typing (MLST) [14] was performed
according to the MLST Database (http://www.pasteur.fr/
recherche/genopole/PF8/mlst/). Six representative strains of
K. pneumoniae PFGE type K1 (different hospitals, isolated in
2008–2010) were identiﬁed as ST258. The minor PFGE types
belonged to three STs: K2 and K5 to ST11, a single-locus
variant of ST258; K3 to ST476; and K4 to the new ST526
described here.
The genetic surroundings of blaKPC-2 were studied by PCR
mapping and sequencing (see primers used in the Supporting
Information). Two different genetic environments were
found (Fig. 2). All of the 63 K. pneumoniae clone K1/ST258
isolates harboured blaKPC-2 in the Tn4401a isoform [5]. To
analyse the remaining 16 clinical isolates that did not harbour
Tn4401, we constructed EcoRI-based DNA libraries [15]
from C. freundii M9169 [9] and E. cloacae M11180. The
blaKPC-2 environment found was very similar to the so-called
Variant 1 (the accession number was not provided), a variant
of the region found in plasmid pKP048 from a Chinese
K. pneumoniae isolate [7]. Therefore, we named the Argen-
tinean blaKPC-2 environment Variant 1a (Fig. 2a). However,
we found two key differences: a composite transposon (par-
tial sequence) from plasmid pFBAOT6 of Aeromonas punctata
[16], which disrupts tnpA of the Tn801-like transposon, and
an additional 671-bp fragment between ISKpn8 and blaKPC-2,
which contains a truncated blaTEM-1.
By PCR mapping (Fig. 2b), Variant 1a was detected in 14 of
16 isolates, whereas the remaining two showed the new Vari-
ant 1b (Fig. 2a). As a whole, Variants 1a and 1b were found in
ﬁve enterobacterial species, including K. pneumoniae ST11,
ST476, and ST526. Interestingly, ST11 was also described in
two KPC-producing PFGE clones from Brazil, but these har-
boured a Tn4401 [17], in contrast to the ST11 Argentinean
and Chinese [8] isolates. As essentially the same blaKPC-2 envi-
ronment (Variants 1a and 1b) was found in different species,
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FIG. 1. Species distribution of the 77 blaKPC-2-producing isolates in the different time periods. The ﬁrst two KPC-producing isolates collected in
2006 (Citrobacter freundii and Klebsiella pneumoniae NON-ST258) were excluded. For each time period, the number of hospitals where blaKPC-2-
producing isolates were recovered, and the numbers of Kpn-ST258, Kpn-NON-ST258 and other enterobacteria, are shown. Kpn, K. pneumoniae.
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we speculated that a unique plasmid could be responsible for
such interspecies dissemination. However, a plasmid content
analysis [18] of the 16 isolates harbouring Variants 1a and 1b
showed a range of plasmid sizes (7–80 kb), with several iso-
lates harbouring more than one plasmid (data not shown). In
addition, a Southern blot analysis with a blaKPC probe showed
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FIG. 2. Genetic environment of blaKPC-2 in enterobacteria from Argentina. Genes (open reading frames) and their corresponding transcriptional
orientations are indicated by horizontal broad arrows. Filled and empty triangles represent inverted repeats of insertion sequences (ISs) or
Tn3-group transposons, respectively. (a) The Tn4401a sequence was from plasmid pNYC (GenBank accession number EU176011) and the
region of the plasmid pKP048 depicted corresponds to coordinates 15 736 to 25 596 (complement) in GenBank FJ628167. Variant 1a represents
the sequence obtained from Citrobacter freundii M9169 and Enterobacter cloacae M11180 [9] (10 047 bp, GenBank JN048639 and JN048640,
respectively). DblaTEM-1 indicates a deletion of 10 bp upstream of the blaTEM-1 start plus the ﬁrst 291 nucleotides of the encoding gene for the
Tn3 sequence. Only the 58-bp deleted fragment in Variant 1b is shown, indicating the Tn801-like inverted repeat right (underlined text) and its
A/T-rich pentameric target site duplication (TSD). The grey-shaded areas show identical regions among the compared structures. Thick lines
with single or double arrowheads indicate the different ISs or transposons found, and thin lines with double arrowheads indicate the identity
with plasmid pFBAOT6 from Aeromonas punctata (GenBank CR376602). (b) PCR mapping used for characterizing Tn4401a-harbouring (upper)
or Variant 1a/b-harbouring isolates (lower). The amplicons obtained in the different PCR assays and the lengths (bp) of the different amplicons
are represented by thick lines. The letters and numbers at the left of each line indicate the different PCR used (primers are listed in the Sup-
porting Information). Amplicons 7 and 8 were sequenced in all isolates to discriminate between Variants 1a and 1b.
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that blaKPC-2 was associated with plasmids of different sizes
(data not shown). Therefore, PCR-based replicon typing [19]
was performed on the 16 clinical isolates. We detected a sin-
gle Inc group in 11 isolates: IncHI2 (n = 3), IncL/M (n = 3),
and IncA/C (n = 5). Two isolates produced amplicons for
three Inc groups (Escherichia coli, IncFIA–IncFIB–IncFrepB;
K. pneumoniae, K5/ST11, IncL/M–IncA/C–IncFIIS) and three
isolates gave negative results with all of the Inc primers tested
(see Supporting Information).
Biparental conjugation [15] of six representative ST258
isolates (from different hospitals) did not yield transconju-
gants. Interestingly, three of 11 selected isolates (different
hospitals and species) harbouring Variants 1a and 1b yielded
transconjugants: two C. freundii (Variants 1a and 1b) and one
S. marcescens (Variant 1a). b-Lactam MICs [20] of the trans-
conjugants were lower than those of the parental strains
(MIC range, mg/L): cefotaxime, 1–16 vs. 8–64; ceftazidime,
2–16 vs. 4–64; imipenem, 0.5–2 vs. 2–16; meropenem,
0.125–0.5 vs. 2–16; and ertapenem 0.25–1 vs. 2–8 mg/L. Rep-
licon typing analysis allowed us to associate blaKPC-2 with
IncL/M transferable plasmids in two transconjugants, whereas
the remaining one was negative for all of the Inc primers
tested, as was its parental strain.
The present work shows the results of a 3-year study
(2008–2010) conducted in Argentina by the NRLAR to
detect, characterize and warn of KPC emergence. The dis-
semination of blaKPC-2 occurred in two phases (Fig. 1): (i)
from January 2008 to July 2009, with the sporadic occur-
rence of blaKPC-2 in diverse enterobacteria obtained from
distant locations; and (ii) since August 2009, with a six-fold
increase in the number of blaKPC-2 isolates, 94% of which
were ST258. Therefore, the abrupt dissemination of KPC in
Argentina could be explained by the surge of a unique clone
of the international ST258. Moreover, the fact that Tn4401a
was only found among these isolates reinforces the notion of
clonal expansion in our hospital settings. Conversely, phase 1
of the local KPC emergence was driven by a diversity of
enterobacterial species harbouring plasmids of several incom-
patibility groups. However, these isolates harboured blaKPC-2
in a unique and unusual genetic environment (Variants 1a
and 1b) that was transferable by conjugation. These facts
strongly suggest that not only plasmid transferability but also
blaKPC-2 mobilization among different plasmids (i.e. transposi-
tion) could have played a major role in phase 1 of the
Argentinean KPC emergence, leading to dissemination of
Variants 1a and 1b in diverse clones and species.
To conclude, the actual KPC epidemiology in Argentina is
complex and diverse. Cooperative efforts and strict infection
control policies are still required in all institutions afﬂicted
by dissemination of KPC.
The nucleotide sequences obtained here have been assigned
GenBank accession numbers JN048639 and JN048640 (Vari-
ant 1a), and JN048641 and JN048642 (Variant 1b).
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Genetic diversity of carbapenem-
hydrolysing b-lactamases in Acinetobacter
baumannii from Romanian hospitals
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Abstract
Thirteen carbapenem-resistant Acinetobacter baumannii isolates,
collected in Romania during 2009–2010, were investigated to
identify the mechanism(s) responsible for carbapenem resistance.
Genotyping was performed by pulsed-ﬁeld gel electrophoresis,
multiplex PCR sequence typing and multilocus sequence typing.
Eleven non-clonally related isolates harboured the blaOXA-23
gene on their chromosome within a Tn2008 transposon struc-
ture. The two remaining isolates harboured a blaOXA-58 gene
that was either plasmid or chromosome borne. Two isolates
co-expressed OXA-23 together with the extended-spectrum
b-lactamase PER-1. This study constitutes the ﬁrst report of
OXA-58 and OXA-23-producing A. baumannii isolates in
Romania.
Keywords: Acinetobacter baumannii, carbapenemase, extended-
spectrum b-lactamase, OXA-23, OXA-58
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